As blockbuster weight-loss drugs surge in India, regulators warn that "awareness campaigns" may be blurring the line between public health messaging and pharmaceutical marketing.

PRESIDENT Donald Trump announced Thursday that he would remove Kristi Noem as Homeland Security secretary after she faced ...

India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates ...

COLUMBUS, Ohio—For more than a year, Republican Vivek Ramaswamy has been raising record amounts of cash for his 2026 gubernatorial campaign. On Thursday, he began spending it in earnest. Ramaswamy’s ...

The Central Drugs Standard Control Organization (CDSCO) has issued an advisory cautioning pharmaceutical companies against direct or indirect promotional activities related to ...

Government warns pharmaceutical companies against indirectly promoting prescription weight-loss medicines. Authorities stress that obesity treatment must focus on lifestyle changes, not marketing ...

A faith-based medical provider is pushing back against an advertising company’s refusal to display a billboard campaign promoting its abortion pill reversal services, a decision that the organization ...

Joshua Jackson is using humor and an unexpected co-star to start an important conversation about cancer screening. In an exclusive interview, the actor explains why many men avoid talking to their ...

These ads share more than bad taste. They reflect industries that knew, or should have known, the harm they were causing and ...

By Rishika Sadam March 11 (Reuters) - India's drug regulator has warned pharmaceutical companies against direct or indirect advertising of weight-loss medicines, including obesity awareness campaigns ...

India's CDSCO has warned pharma firms against promoting prescription weight-loss drugs (GLP-1s) via surrogate or digital ads, ...

India’s Central Drugs Standard Control Organization warns pharma companies against promoting GLP-1 receptor agonists directly to consumers.